NPCE RNS System Explained: Growth Drivers and Setup for 2026

NPCE enters 2026 with rising RNS adoption, stronger margins and Medicare payment hikes that could boost hospital economics for replacement procedures.
Seeking Alpha

NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting

MOUNTAIN VIEW, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced three-year ...

NeuroPace's Seizure ID and New Indication Could Expand RNS Demand

NPCE's Seizure ID AI tool and potential idiopathic generalized epilepsy approval could expand RNS adoption as NeuroPace pushes software-driven care in 2026.
Nasdaq

NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting

MOUNTAIN VIEW, Calif., Dec. 01, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, ...
Nasdaq

NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome

MOUNTAIN VIEW, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, ...

NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, ...
Morningstar

NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its RNS System and NeuroPace AI platform will be ...
Kaleido Scope

Children’s of Alabama performs first deep brain stimulation procedure for epilepsy, implants first responsive neurostimulation treatment device

A University of Alabama at Birmingham pediatric neurosurgeon has performed the first deep brain stimulation (DBS) procedure for epilepsy at Children’s of Alabama (COA), offering a new treatment option ...
Healio

Q&A: Neuromodulation device effective for drug-resistant focal epilepsy, 3-year data show

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Neuromodulation offers personalized, responsive ...
Seeking Alpha

NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting

MOUNTAIN VIEW, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- December 4, 2024 – NeuroPace, Inc. (NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today ...